Navigation Links
Experimental Flu Vaccine Appears Promising in Early Tests

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response// in healthy adults. The new research promises to be an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study.

"All currently licensed influenza vaccines in the United States are produced in embryonated hen's eggs. There are several well-recognized disadvantages to the use of eggs as the substrate [the base on which an organism lives or grows] for influenza vaccine. Eggs require specialized manufacturing facilities and could be difficult to scale up rapidly in response to an emerging need such as a pandemic," the authors write. They add that development of alternative substrates for influenza vaccine production has been identified as a high-priority. One potential alternative is use of the influenza virus hemagglutinin (HA; an antibody that causes red blood cells to clump together) using recombinant (genetic recombination) DNA techniques.

John J. Treanor, M.D., of the University of Rochester, N.Y., and colleagues evaluated an experimental influenza vaccine consisting of recombinant HA expressed in insect cells by a recombinant baculovirus (rHA0). The clinical trial was conducted at three U.S. academic medical centers during the 2004-2005 influenza season and included 460 healthy adults. Participants were randomly assigned to receive a single injection of saline placebo (n = 154); 75 μg of an rHA0 vaccine containing 15 μg of hemagglutinin from influenza A/New Caledonia/20/99(H1N1) and influenza B/Jiangsu/10/03 virus and 45 μg of hemagglutinin from influenza A/Wyoming/3/03 (H3N2) virus (n = 153); or 135 μg of rHA0 containing 45 μg of hemagglutinin each from all 3 components (n = 153). Serum samples were taken before and 30 days following immunization.

The researchers found: "We have shown that the rHA0 vaccine is well tolerated in healthy adults and immunogenic at
'"/>




Page: 1 2

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Experimental drug to fight flu
3. Experimental SARS Vaccine
4. Experimental vaccine for shingles is effective
5. Experimental Blood Test May Spot Heart Attack Risk, Study Says
6. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
7. Protection against HIV and Herpes is possible with the Experimental Microbicide
8. Experimental Therapy Effective Against Malignant Melanoma in Horses
9. Experimental Alzheimer’s Drug curbs the disease in mic
10. New Guidelines to Be Laid While Testing Experimental Drugs
11. Experimental Drug Deals Effectively with Prostate Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Experimental Flu Vaccine Appears Promising Early Tests

(Date:2/28/2015)... 2015 A case management conference ( ... have been filed by law firms including Bernstein Liebhard ... March, the Firm notes. , According to a ... the federal litigation will meet on March 13, 2015 ... therapy treatments designed to raise levels of the male ...
(Date:2/28/2015)... The noted Friedman Dental Group of South Florida ... their website. The new version of the site is ... section about their team members. Potential and current patients ... each Friedman Dental Group team member including new staff. ... provide our patients with the opportunity to get to ...
(Date:2/28/2015)... 2015 “ Powermod ” was featured on ... a look at the latest and coolest technology products and ... NewsWatch and a technology expert, conducted the review and shared ... solutions. , Getting stuck with a low battery and no ... that people face on a daily basis. Even when a ...
(Date:2/28/2015)... Las Vegas, NV (PRWEB) February 28, 2015 ... products, will be sending a team to Las Vegas, Nevada ... ASD Market Week is one of the leading consumer-goods tradeshows ... 2,600 vendors at this year’s event. My Shiney Hiney can ... delivers a fresh, modern design for the at-home personal hygiene ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
Breaking Medicine News(10 mins):Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3
... HealthDay Reporter , TUESDAY, Jan. 24 (HealthDay News) ... treat an enlarged prostate gland, may help slow the progression ... treatment in some men. Prostate cancer can grow and ... engage in so-called watchful waiting when the cancer is first ...
... cardiovascular disease and diabetes risk is present in the ... a scenario that worsens in the face of excess ... 559 adolescents age 14-18 correlated high-fructose diets with higher ... that contribute to heart and vascular disease. , ...
... This release is available in German . ... that precursors of cervical cancer can be detected and treated ... underwent testing for human papillomavirus (HPV). In this context, an ... a Papanicolaou test (Pap smear). However, both screening procedures also ...
... , MONDAY, Jan. 23 (HealthDay News) -- Since the U.S. ... safety of medical procedures used to terminate pregnancy. Now, ... safer than carrying a baby to term. The risk ... 8.8 deaths per 100,000, while the risk of death linked ...
... ANN ARBOR, Mich. -- Only about one in five young ... the 2009-2010 swine flu epidemic, according to a University of ... X. But about 65 percent were at least moderately ... were following the issue very or moderately closely. Using ...
... , MONDAY, Jan. 23 (HealthDay News) -- Marriage offers few ... The study also found that the benefits of marriage ... greater happiness and self-esteem. Researchers examined data from 2,737 ... National Survey of Families and Households. Of those people, 896 ...
Cached Medicine News:Health News:Drug May Slow Early Prostate Cancer: Study 2Health News:High fructose consumption by adolescents may put them at cardiovascular risk 2Health News:HPV testing: Indications of a benefit in primary screening 2Health News:HPV testing: Indications of a benefit in primary screening 3Health News:HPV testing: Indications of a benefit in primary screening 4Health News:Abortion Safer for Women Than Childbirth, Study Claims 2Health News:Abortion Safer for Women Than Childbirth, Study Claims 3Health News:Generation X: How young adults deal with influenza 2Health News:Living Together May Be Mentally Healthier Than Marriage: Study 2
(Date:2/27/2015)... 2015  Following a bipartisan vote in the ... 284, the Medicare DMEPOS Competitive Bidding Improvement Act ... (AAHomecare) released a statement praising the Committee,s work ... legislation. "Today,s mark-up of the Competitive ... Means Committee is a critical step forward for ...
(Date:2/27/2015)... VANCOUVER, Canada and HOUSTON, TX ... ("ESSA" or the "Company") (TSX-V: EPI) and Bloom Burton ... have released from voluntary contractual lock-up (the "Lock-Up") 2,353,130 ... of the Common Shares originally subject to the Lock-Up. ... shares will be free trading immediately upon release from ...
(Date:2/27/2015)... Mass. , Feb. 27, 2015   Synageva ... ), a biopharmaceutical company developing therapeutic products for ... Disorders™ (NORD™), the European Organisation for Rare Diseases™ ... the world in observing Rare Disease Day. ... year, patient organizations, industry, and other participants conduct ...
Breaking Medicine Technology:Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... ORLANDO, Fla., Sept. 16 LightPath Technologies, Inc. (Nasdaq: ... a global manufacturer, distributor and integrator of patented optical ... for the fourth quarter and fiscal year ended June ... Company,s preliminary results issued on August 25, 2010. Full ...
... WORTH, Texas, Sept. 16 Wound Management Technologies, ... announced today that its subsidiary, Wound Care Innovations, ... International, LLC (Bivium) to distribute its advanced wound ... International will be introducing Cellerate RX® to the ...
Cached Medicine Technology:LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 2LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 3LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 4LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 5LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 6LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 7LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 8LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 9LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 10LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 11LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 12LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 13LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 14LightPath Technologies Announces Fourth Quarter and Fiscal 2010 Financial Results 15Wound Management Technologies Adds Panama to Growing List of Distribution Points in Central America 2Wound Management Technologies Adds Panama to Growing List of Distribution Points in Central America 3
... 2 eyes, oral. Marked with recommended ... opaque line. Graduated. Single use. For ... kinking of the tube by incorporating ... to the anatomical situation at body ...
... Slick Set® Tube with stylet inside. ... quality uncuffed Rusch endotracheal tube with ... to use saving you time and ... coded for easy identification and has ...
... Rusch Safety Clear Plus™ Cuffed Endotracheal Tube ... stylet inside. Sterile, Single use. A quality Rusch ... ready to use saving you time and storage ... to facilitate smooth withdrawal. It is designed with ...
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff. Permanent connector. X-ray opaque. Single use. Sterile...
Medicine Products: